https://news.medxy.ai/zh/78182-2/Medxy AIzh2026-09-27T07:27:14-07:00房颤消融术后的卒中与体循环栓塞：来自 EMBOL-AF 全球注册研究及当代循证医学证据的启示 https://news.medxy.ai/ja/78181-2/Medxy AIja2026-09-27T07:26:53-07:00心房細動アブレーション後の脳卒中および全身性塞栓症：EMBOL-AFグローバルレジストリおよび最新のエビデンスからの知見 https://news.medxy.ai/vi/78180-2/Medxy AIvi2026-09-27T07:26:24-07:00Đột quỵ và thuyên tắc hệ thống sau thủ thuật triệt đốt rung nhĩ: Những hiểu biết từ cơ sở dữ liệu toàn cầu EMBOL-AF và các bằng chứng hiện đại https://news.medxy.ai/stroke-and-systemic-embolism-following-atrial-fibrillation-ablation-insights-from-the-embol-af-global-registry-and-contemporary-evidence/Medxy AIen2026-09-27T07:26:01-07:00Stroke and Systemic Embolism Following Atrial Fibrillation Ablation: Insights from the EMBOL-AF Global Registry and Contemporary Evidence https://news.medxy.ai/zh/non-contrast-mra/Medxy AIzh2026-09-27T07:19:15-07:00无对比剂磁共振血管成像：DIEP皮瓣术前规划中替代增强CT的安全高效方案 https://news.medxy.ai/ja/78014-2/Medxy AIja2026-09-27T07:18:55-07:00造影剤を用いないMRA：DIEP皮弁術の術前計画において造影CTに代わる安全かつ効率的な手法 https://news.medxy.ai/vi/78012-2/Medxy AIvi2026-09-27T07:18:35-07:00Chụp mạch cộng hưởng từ không dùng thuốc đối quang có thể thay thế chụp cắt lớp vi tính (CT) có tiêm thuốc đối quang trong lập kế hoạch phẫu thuật vạt DIEP https://news.medxy.ai/noncontrast-magnetic-resonance-angiography-as-a-noninferior-and-safer-alternative-to-contrast-enhanced-ct-in-diep-flap-planning-insights-from-a-4-year-cohort-study/Medxy AIen2026-09-27T07:18:15-07:00Noncontrast Magnetic Resonance Angiography as a Noninferior and Safer Alternative to Contrast-Enhanced CT in DIEP Flap Planning: Insights from a 4-Year Cohort Study https://news.medxy.ai/zh/dupuytren-treatment-comparison/Medxy AIzh2026-09-27T07:17:29-07:00复发性Dupuytren挛缩：手术筋膜切除术与胶原酶注射的最佳管理比较 https://news.medxy.ai/ja/dupuytren-contracture-treatment/Medxy AIja2026-09-27T07:17:09-07:00再発性デュピュイトラン拘縮：最適治療を探る外科的筋膜切除術とコラゲナーゼ注射の比較 https://news.medxy.ai/vi/dupuytren-treatment-comparison-2/Medxy AIvi2026-09-27T07:16:45-07:00Co rút Dupuytren tái phát: So sánh phẫu thuật cắt cân gan tay và tiêm collagenase để tối ưu hóa điều trị https://news.medxy.ai/recurrent-dupuytren-contracture-comparing-surgical-fasciectomy-and-collagenase-injection-for-optimal-management/Medxy AIen2026-09-27T07:16:27-07:00Recurrent Dupuytren Contracture: Comparing Surgical Fasciectomy and Collagenase Injection for Optimal Management https://news.medxy.ai/zh/breast-reconstruction-outcomes/Medxy AIzh2026-09-27T07:15:46-07:00放疗后乳房重建：胸肌前位与胸肌后位植入物的长期结局前瞻性比较 https://news.medxy.ai/ja/77993-2/Medxy AIja2026-09-27T07:15:26-07:00放射線療法後の乳房再建：胸筋前および胸筋後へのインプラント留置における長期成績の比較（前向き研究） https://news.medxy.ai/vi/breast-reconstruction-after-radiation/Medxy AIvi2026-09-27T07:15:03-07:00Tái tạo vú trước cơ hay dưới cơ sau xạ trị: Phân tích tiến cứu về kết cục dài hạn https://news.medxy.ai/prepectoral-vs-subpectoral-breast-reconstruction-after-radiotherapy-a-prospective-long-term-outcome-analysis/Medxy AIen2026-09-27T07:14:45-07:00Prepectoral vs. Subpectoral Breast Reconstruction After Radiotherapy: A Prospective Long-Term Outcome Analysis https://news.medxy.ai/zh/ai-nose-surgery-detection/Medxy AIzh2026-09-27T07:13:58-07:00AI 识别线上鼻整形术照片中的数字篡改：推动手术透明化的新方向 https://news.medxy.ai/ja/ai-rhinoplasty-detection/Medxy AIja2026-09-27T07:13:37-07:00AIがオンライン鼻形成術写真の改変を検出：外科的透明性を高める新たな展開 https://news.medxy.ai/vi/ai-nose-job-detection/Medxy AIvi2026-09-27T07:13:18-07:00AI phát hiện ảnh nâng mũi trực tuyến bị chỉnh sửa kỹ thuật số: Bước tiến mới trong minh bạch phẫu thuật https://news.medxy.ai/ai-detects-digital-manipulation-in-online-rhinoplasty-photos-a-new-frontier-for-surgical-transparency/Medxy AIen2026-09-27T07:12:59-07:00AI Detects Digital Manipulation in Online Rhinoplasty Photos: A New Frontier for Surgical Transparency https://news.medxy.ai/zh/nmdar-brain-structure/Medxy AIzh2026-09-27T07:12:17-07:00NMDAR脑炎的脑结构改变与长期预后：德国横断面研究带来的新认识 https://news.medxy.ai/ja/nmda-encephalitis-brain-structure/Medxy AIja2026-09-27T07:11:57-07:00NMDA受容体脳炎の脳構造変化と長期転帰：ドイツ横断研究が示す新知見 https://news.medxy.ai/vi/nmda-encephalitis-brain-structure-2/Medxy AIvi2026-09-27T07:11:34-07:00Thay đổi cấu trúc não và kết cục dài hạn ở viêm não thụ thể NMDA: Góc nhìn từ một nghiên cứu cắt ngang tại Đức https://news.medxy.ai/structural-brain-changes-and-long-term-outcomes-in-nmda-receptor-encephalitis-insights-from-a-german-cross-sectional-study/Medxy AIen2026-09-27T07:11:15-07:00Structural Brain Changes and Long-Term Outcomes in NMDA Receptor Encephalitis: Insights from a German Cross-Sectional Study https://news.medxy.ai/zh/continuous-ketamine-infusion/Medxy AIzh2026-09-27T07:10:33-07:00连续静脉氯胺酮输注为难治性双相抑郁带来新希望：一项突破性随机试验 https://news.medxy.ai/ja/77972-2/Medxy AIja2026-09-27T07:10:17-07:00ケタミンの持続静脈内投与が難治性双極性うつ病に新たな希望をもたらす：画期的な無作為化試験 https://news.medxy.ai/vi/ketamine-bipolar-depression/Medxy AIvi2026-09-27T07:09:56-07:00Ketamine truyền nhiều đợt cho thấy triển vọng trong điều trị trầm cảm lưỡng cực kháng trị: kết quả từ một thử nghiệm ngẫu nhiên đột phá https://news.medxy.ai/serial-ketamine-infusions-show-promise-in-treatment-resistant-bipolar-depression-a-groundbreaking-randomized-trial/Medxy AIen2026-09-27T07:09:36-07:00Serial Ketamine Infusions Show Promise in Treatment-Resistant Bipolar Depression: A Groundbreaking Randomized Trial https://news.medxy.ai/zh/ace-in-early-psychosis/Medxy AIzh2026-09-27T07:08:52-07:00早期精神病中的血管紧张素转换酶：潜在生物标志物与治疗靶点 https://news.medxy.ai/ja/early-psychosis-biomarkers/Medxy AIja2026-09-27T07:08:36-07:00早期精神病におけるバイオマーカーと治療標的としてのアンジオテンシン変換酵素 https://news.medxy.ai/vi/ace-biomarker-target/Medxy AIvi2026-09-27T07:08:19-07:00ACE: Dấu ấn sinh học và đích điều trị tiềm năng trong rối loạn loạn thần giai đoạn sớm https://news.medxy.ai/angiotensin-converting-enzyme-as-a-biomarker-and-therapeutic-target-in-early-stage-psychosis/Medxy AIen2026-09-27T07:08:02-07:00Angiotensin-Converting Enzyme as a Biomarker and Therapeutic Target in Early-Stage Psychosis https://news.medxy.ai/zh/parental-similarity-mental-disorders/Medxy AIzh2026-09-27T07:07:24-07:00揭示择偶同类配对：父母相似性如何影响精神障碍的遗传率与人群患病率 https://news.medxy.ai/ja/selective-breeding-mental-illness/Medxy AIja2026-09-27T07:07:06-07:00精神疾患の選択的交配を読み解く：親の類似性が疾患の遺伝率と人口有病率をどう左右するか https://news.medxy.ai/vi/selective-mating-genetics/Medxy AIvi2026-09-27T07:06:48-07:00Giải mã giao phối chọn lọc: Tính tương đồng giữa cha mẹ định hình tính di truyền và tỷ lệ hiện mắc rối loạn tâm thần ở cấp độ quần thể https://news.medxy.ai/unraveling-assortative-mating-how-parental-similarity-shapes-psychiatric-disorder-heritability-and-prevalence-at-the-population-level/Medxy AIen2026-09-27T07:06:31-07:00Unraveling Assortative Mating: How Parental Similarity Shapes Psychiatric Disorder Heritability and Prevalence at the Population Level https://news.medxy.ai/zh/chatgpt4o-icu-review/Medxy AIzh2026-09-27T07:05:53-07:00重症医学专科复习题中的 ChatGPT-4o：准确率高，但多模态解读存在风险 https://news.medxy.ai/ja/chatgpt4o-icu-evaluation/Medxy AIja2026-09-27T07:05:35-07:00集中治療ボード試験でのChatGPT-4o評価：高精度だがマルチモーダル解釈に課題 https://news.medxy.ai/vi/77941-2/Medxy AIvi2026-09-27T07:05:16-07:00ChatGPT-4o trong các câu hỏi ôn tập chuyên ngành Y học Hồi sức tích cực: Độ chính xác cao nhưng tiềm ẩn rủi ro trong việc diễn giải đa phương thức https://news.medxy.ai/evaluating-chatgpt-4o-in-critical-care-board-review-high-accuracy-but-risky-multimodal-interpretations/Medxy AIen2026-09-27T07:04:58-07:00Evaluating ChatGPT-4o in Critical Care Board Review: High Accuracy but Risky Multimodal Interpretations https://news.medxy.ai/zh/esophageal-ultrasound-shock/Medxy AIzh2026-09-27T07:04:20-07:00经食管肺部超声联合复苏性经食管超声心动图：休克评估的新进展与临床可行性 https://news.medxy.ai/ja/shock-assessment-enhancement/Medxy AIja2026-09-27T07:04:01-07:00ショック評価をさらに高精度に：蘇生TEE併用経食道肺超音波の実現可能性と臨床的意義 https://news.medxy.ai/vi/lung-ultrasound-feasibility/Medxy AIvi2026-09-27T07:03:36-07:00Nâng cao đánh giá sốc: tính khả thi và tác động của siêu âm phổi qua thực quản kết hợp với siêu âm tim qua thực quản hồi sức https://news.medxy.ai/enhancing-shock-evaluation-feasibility-and-impact-of-transesophageal-lung-ultrasound-combined-with-resuscitative-transesophageal-echocardiography/Medxy AIen2026-09-27T07:03:19-07:00Enhancing Shock Evaluation: Feasibility and Impact of Transesophageal Lung Ultrasound Combined with Resuscitative Transesophageal Echocardiography https://news.medxy.ai/zh/pediatric-sepsis-care/Medxy AIzh2026-09-27T07:02:31-07:00揭示儿童脓毒症住院前医疗接触：早期识别与干预的新机会 https://news.medxy.ai/ja/pediatric-sepsis-early-care/Medxy AIja2026-09-27T07:02:11-07:00小児敗血症の入院前医療受診に着目する：早期発見・介入の機会 https://news.medxy.ai/vi/pediatric-sepsis-care-2/Medxy AIvi2026-09-27T07:01:52-07:00Nhận diện các lần tiếp xúc y tế trước nhập viện ở nhiễm trùng huyết nhi khoa: Cơ hội phát hiện sớm và can thiệp kịp thời https://news.medxy.ai/unveiling-pre-hospitalization-healthcare-encounters-in-pediatric-sepsis-opportunities-for-early-detection-and-intervention/Medxy AIen2026-09-27T07:01:33-07:00Unveiling Pre-Hospitalization Healthcare Encounters in Pediatric Sepsis: Opportunities for Early Detection and Intervention https://news.medxy.ai/zh/nt-probnp-interpretation/Medxy AIzh2026-09-27T06:00:51-07:00住院成人极高 NT-proBNP 的临床解读：不止于心力衰竭 https://news.medxy.ai/ja/nt-probnp-complexity/Medxy AIja2026-09-27T06:00:34-07:00入院患者の超高値NT-proBNPを読み解く：心不全だけではない臨床的複雑性 https://news.medxy.ai/vi/nt-probnp-high/Medxy AIvi2026-09-27T06:00:14-07:00NT-proBNP tăng cực cao ở bệnh nhân nhập viện: không chỉ là suy tim https://news.medxy.ai/unraveling-the-clinical-complexity-of-extremely-high-nt-probnp-in-hospitalized-adults-beyond-heart-failure/Medxy AIen2026-09-27T05:59:54-07:00Unraveling the Clinical Complexity of Extremely High NT-proBNP in Hospitalized Adults: Beyond Heart Failure https://news.medxy.ai/zh/ai-home-care-insights/Medxy AIzh2026-09-26T06:59:14-07:00洞察家庭护理中的 AI：关键利益相关方的观点与证据综述 https://news.medxy.ai/ja/ai-home-care-stakeholders/Medxy AIja2026-09-26T06:58:57-07:00在宅ケアにおけるAI活用をめぐる主要ステークホルダーの視点：エビデンスに基づく総説 https://news.medxy.ai/vi/ai-home-care-overview/Medxy AIvi2026-09-26T06:58:38-07:00Góc nhìn của các bên liên quan về trí tuệ nhân tạo trong công việc chăm sóc tại nhà: Tổng quan dựa trên bằng chứng https://news.medxy.ai/understanding-key-stakeholders-perspectives-towards-artificial-intelligence-in-home-care-work-an-evidence-based-review/Medxy AIen2026-09-26T06:58:17-07:00Understanding Key Stakeholders’ Perspectives Towards Artificial Intelligence in Home Care Work: An Evidence-Based Review https://news.medxy.ai/zh/medical-communication-evolution/Medxy AIzh2026-09-26T06:57:30-07:00从入门到精通：内科医生医疗目标沟通能力的演进——一项跨培训阶段质性研究 https://news.medxy.ai/ja/goals-of-care-dialogue/Medxy AIja2026-09-26T06:57:12-07:00内科医におけるGoals-of-Care対話能力の発達：研修段階を通じた質的研究からの示唆 https://news.medxy.ai/vi/care-goal-discussion/Medxy AIvi2026-09-26T06:56:51-07:00Năng lực thảo luận về mục tiêu chăm sóc ở bác sĩ nội khoa: Góc nhìn từ một nghiên cứu định tính theo các giai đoạn đào tạo https://news.medxy.ai/evolving-competence-in-goals-of-care-discussions-among-internal-medicine-physicians-insights-from-a-qualitative-study-across-training-levels/Medxy AIen2026-09-26T06:56:33-07:00Evolving Competence in Goals-of-Care Discussions Among Internal Medicine Physicians: Insights from a Qualitative Study Across Training Levels https://news.medxy.ai/ja/tobacco-use-treatment/Medxy AIja2026-09-26T06:55:52-07:00タバコ使用治療：2026年VA/DoD臨床実践ガイドラインの要点 https://news.medxy.ai/vi/smoking-dependence-treatment/Medxy AIvi2026-09-26T06:55:19-07:00Điều trị lệ thuộc thuốc lá: Những điểm chính từ Hướng dẫn lâm sàng VA/DoD 2026 https://news.medxy.ai/zh/tobacco-use-treatment-2/Medxy AIzh2026-09-26T06:54:48-07:00烟草使用治疗：2026 年 VA/DoD 临床实践指南要点 https://news.medxy.ai/tobacco-use-treatment-key-points-from-the-2026-va-dod-clinical-practice-guideline/Medxy AIen2026-09-26T06:54:21-07:00Tobacco Use Treatment: Key Points from the 2026 VA/DoD Clinical Practice Guideline https://news.medxy.ai/zh/b-cell-lymphoma/Medxy AIzh2026-09-26T06:53:08-07:00解码大B细胞淋巴瘤异质性：单细胞图谱揭示与患者结局相关的恶性细胞原型 https://news.medxy.ai/ja/b-cell-lymphoma-2/Medxy AIja2026-09-26T06:52:50-07:00大B細胞リンパ腫の異質性を解読する：単一細胞アトラスが患者転帰に関連する悪性アーキタイプを同定 https://news.medxy.ai/vi/b-cell-lymphoma-heterogeneity/Medxy AIvi2026-09-26T06:52:28-07:00Giải mã tính dị hợp của u lympho tế bào B lớn: Bản đồ đơn bào xác định các kiểu hình ác tính liên quan đến kết cục người bệnh https://news.medxy.ai/decoding-large-b-cell-lymphoma-heterogeneity-a-single-cell-atlas-identifies-malignant-archetypes-linked-to-patient-outcomes/Medxy AIen2026-09-26T06:52:08-07:00Decoding Large B Cell Lymphoma Heterogeneity: A Single-Cell Atlas Identifies Malignant Archetypes Linked to Patient Outcomes https://news.medxy.ai/zh/aml-transplant-optimization/Medxy AIzh2026-09-26T06:51:05-07:00借助微小残留病检测优化成人急性髓系白血病的异基因造血细胞移植 https://news.medxy.ai/ja/mrd-testing-adult-aml/Medxy AIja2026-09-26T06:50:47-07:00MRD検査で成人AMLの同種造血細胞移植を個別化する https://news.medxy.ai/vi/blood-stem-cell-transplant/Medxy AIvi2026-09-26T06:50:26-07:00Cá thể hóa ghép tế bào tạo máu đồng loài ở người lớn mắc AML bằng xét nghiệm MRD https://news.medxy.ai/personalizing-allogeneic-hematopoietic-cell-transplantation-in-adult-aml-using-measurable-residual-disease-testing/Medxy AIen2026-09-26T06:50:05-07:00Personalizing Allogeneic Hematopoietic Cell Transplantation in Adult AML Using Measurable Residual Disease Testing https://news.medxy.ai/zh/soluble-bcma/Medxy AIzh2026-09-26T06:49:20-07:00可溶性 BCMA：界定新诊断多发性骨髓瘤肿瘤表型与预后的关键生物标志物 https://news.medxy.ai/ja/soluble-bcma-myeloma/Medxy AIja2026-09-26T06:49:02-07:00新規診断多発性骨髄腫における腫瘍フェノタイプと予後を規定する鍵：可溶性BCMA https://news.medxy.ai/vi/sbcmadissoluble-biomarker-tumor-myeloma/Medxy AIvi2026-09-26T06:48:42-07:00sBCMA hòa tan: Dấu ấn sinh học then chốt định nghĩa kiểu hình khối u và tiên lượng trong đa u tủy mới chẩn đoán https://news.medxy.ai/soluble-bcma-as-a-key-biomarker-defining-tumor-phenotypes-and-prognosis-in-newly-diagnosed-multiple-myeloma/Medxy AIen2026-09-26T06:48:21-07:00Soluble BCMA as a Key Biomarker Defining Tumor Phenotypes and Prognosis in Newly Diagnosed Multiple Myeloma https://news.medxy.ai/zh/ml-weight-loss-risk/Medxy AIzh2026-09-26T06:47:32-07:00解读型机器学习助力减重手术候选者肥胖低通气综合征个体化风险预测 https://news.medxy.ai/ja/personalized-ohs-risk-prediction/Medxy AIja2026-09-26T06:47:13-07:00肥満手術候補患者における個別化OHSリスク予測を実現する説明可能機械学習 https://news.medxy.ai/vi/obesity-ventilation-risk-prediction/Medxy AIvi2026-09-26T06:46:52-07:00Dự báo nguy cơ hội chứng giảm thông khí do béo phì cá thể hóa ở ứng viên phẫu thuật bariatric bằng học máy có khả năng giải thích https://news.medxy.ai/harnessing-explainable-machine-learning-for-personalized-obesity-hypoventilation-syndrome-risk-prediction-in-bariatric-surgery-candidates/Medxy AIen2026-09-26T06:46:32-07:00Harnessing Explainable Machine Learning for Personalized Obesity Hypoventilation Syndrome Risk Prediction in Bariatric Surgery Candidates https://news.medxy.ai/zh/igg-dynamics-monitoring/Medxy AIzh2026-09-26T06:45:44-07:00时间标准化抗曲霉菌IgG动态：监测慢性肺曲霉病进展的新工具 https://news.medxy.ai/ja/chronic-aspergillosis-monitoring/Medxy AIja2026-09-26T06:45:24-07:00時間正規化抗Aspergillus IgG動態による新たな慢性肺アスペルギルス症モニタリング指標 https://news.medxy.ai/vi/igg-kinetics-aspergillus/Medxy AIvi2026-09-26T06:45:02-07:00Động học IgG kháng Aspergillus được chuẩn hóa theo thời gian: công cụ mới để theo dõi tiến triển aspergillosis phổi mạn tính https://news.medxy.ai/time-normalized-anti-aspergillus-igg-kinetics-a-novel-tool-to-monitor-chronic-pulmonary-aspergillosis-progression/Medxy AIen2026-09-26T06:44:44-07:00Time-Normalized Anti-Aspergillus IgG Kinetics: A Novel Tool to Monitor Chronic Pulmonary Aspergillosis Progression https://news.medxy.ai/zh/cftr-antibiotics-impact/Medxy AIzh2026-09-26T06:44:04-07:00CFTR调节剂时代吸入抗生素对囊性纤维化肺功能影响的变化 https://news.medxy.ai/ja/77879-2/Medxy AIja2026-09-26T06:43:48-07:00CFTR調節薬の時代における、嚢胞性線維症の肺機能に対する吸入抗菌薬の影響の変化 https://news.medxy.ai/vi/77878-2/Medxy AIvi2026-09-26T06:43:28-07:00Những thay đổi về tác động của thuốc kháng sinh dạng hít đối với chức năng phổi ở bệnh xơ nang https://news.medxy.ai/evolving-impact-of-inhaled-antibiotics-on-lung-function-in-cystic-fibrosis-during-the-cftr-modulator-era/Medxy AIen2026-09-26T06:43:09-07:00Evolving Impact of Inhaled Antibiotics on Lung Function in Cystic Fibrosis During the CFTR-Modulator Era https://news.medxy.ai/zh/copd-spray-cb/Medxy AIzh2026-09-26T06:42:27-07:00创新性冷冻喷雾治疗为 COPD 合并慢性支气管炎带来新希望：SPRAY-CB 试验解读 https://news.medxy.ai/ja/copd-cryospray-treatment/Medxy AIja2026-09-26T06:42:08-07:00COPDの慢性気管支炎に新たな可能性：SPRAY-CB試験が示したクリオスプレー治療の有望性 https://news.medxy.ai/vi/cryospray-copd-treatment/Medxy AIvi2026-09-26T06:41:51-07:00Cryospray nitơ lỏng sáng tạo cho thấy triển vọng trong điều trị viêm phế quản mạn tính ở bệnh nhân COPD: Góc nhìn từ thử nghiệm SPRAY-CB https://news.medxy.ai/innovative-cryospray-therapy-shows-promise-for-chronic-bronchitis-in-copd-patients-insights-from-the-spray-cb-trial/Medxy AIen2026-09-26T06:41:33-07:00Innovative Cryospray Therapy Shows Promise for Chronic Bronchitis in COPD Patients: Insights from the SPRAY-CB Trial https://news.medxy.ai/zh/77870-2/Medxy AIzh2026-09-26T06:40:53-07:00按吸烟状况分析重症哮喘患者使用生物制剂的转归：来自SHARP欧洲注册研究的启示 https://news.medxy.ai/ja/severe-asthma-treatment/Medxy AIja2026-09-26T06:40:31-07:00喫煙状況別にみた重症喘息における生物学的製剤の転帰：SHARP欧州レジストリからの示唆 https://news.medxy.ai/vi/biologic-therapy-severe-asthma/Medxy AIvi2026-09-26T06:40:07-07:00Kết cục của liệu pháp sinh học ở hen nặng theo tình trạng hút thuốc: Góc nhìn từ Sổ đăng ký SHARP châu Âu https://news.medxy.ai/biologic-outcomes-in-severe-asthma-by-smoking-status-insights-from-the-sharp-european-registry/Medxy AIen2026-09-26T06:39:45-07:00Biologic Outcomes in Severe Asthma by Smoking Status: Insights from the SHARP European Registry https://news.medxy.ai/zh/77865-2/Medxy AIzh2026-09-26T06:38:56-07:00结膜黑色素细胞病变的治疗优化：分阶段多维治疗框架 https://news.medxy.ai/ja/conjunctival-melanocytic-lesion-treatment/Medxy AIja2026-09-26T06:38:34-07:00結膜メラノサイト性病変の治療最適化：段階的多角的治療フレームワーク https://news.medxy.ai/vi/optimized-pigment-lesion-treatment/Medxy AIvi2026-09-26T06:38:14-07:00Tối ưu hóa điều trị các tổn thương sắc tố tế bào hắc tố ở kết mạc: khung điều trị đa mô thức theo trình tự https://news.medxy.ai/optimizing-management-of-conjunctival-melanocytic-lesions-a-sequential-multimodal-treatment-framework/Medxy AIen2026-09-26T06:37:54-07:00Optimizing Management of Conjunctival Melanocytic Lesions: A Sequential Multimodal Treatment Framework https://news.medxy.ai/zh/children-nosebleeds-winter/Medxy AIzh2026-09-26T06:37:14-07:00儿童鼻出血真的更爱“冬天发作”吗？一项持续10年的中大西洋地区研究给出新答案 https://news.medxy.ai/ja/pediatric-nosebleeds/Medxy AIja2026-09-26T06:36:55-07:00小児鼻出血の季節性を再検証する：中部大西洋地域における10年間の研究 https://news.medxy.ai/vi/nosebleeds-children-seasonal/Medxy AIvi2026-09-26T06:36:36-07:00Chảy máu mũi ở trẻ em theo mùa: Phân tích hồi cứu kéo dài 10 năm tại vùng Mid-Atlantic https://news.medxy.ai/re-examining-the-seasonal-pattern-of-pediatric-epistaxis-a-decade-long-mid-atlantic-study/Medxy AIen2026-09-26T06:36:16-07:00Re-examining the Seasonal Pattern of Pediatric Epistaxis: A Decade-Long Mid-Atlantic Study https://news.medxy.ai/zh/laryngeal-chondrosarcoma-outcomes/Medxy AIzh2026-09-26T06:35:37-07:00喉软骨肉瘤的长期气道结局与死亡风险：保留功能与肿瘤控制如何平衡 https://news.medxy.ai/ja/77854-2/Medxy AIja2026-09-26T06:35:20-07:00喉軟骨肉腫における長期的な気道転帰と死亡リスク：機能温存と腫瘍制御のバランスをどうとるか https://news.medxy.ai/vi/malignant-laryngeal-cartilage/Medxy AIvi2026-09-26T06:34:58-07:00U sụn ác tính thanh quản: Kết cục đường thở dài hạn và nguy cơ tử vong giữa bảo tồn chức năng và kiểm soát ung thư https://news.medxy.ai/long-term-airway-outcomes-and-mortality-risks-in-laryngeal-chondrosarcoma-balancing-preservation-and-oncological-control/Medxy AIen2026-09-26T06:34:40-07:00Long-Term Airway Outcomes and Mortality Risks in Laryngeal Chondrosarcoma: Balancing Preservation and Oncological Control https://news.medxy.ai/zh/77850-2/Medxy AIzh2026-09-26T06:33:59-07:00与电子健康记录（EHR）集成的结构化手术报告：提升头颈部肿瘤外科的病历记录质量 https://news.medxy.ai/ja/77849-2/Medxy AIja2026-09-26T06:33:41-07:00EHR統合型シノプティック手術記録：頭頸部腫瘍外科手術における記録の質的向上 https://news.medxy.ai/vi/77848-2/Medxy AIvi2026-09-26T06:33:20-07:00Báo cáo phẫu thuật dạng tóm tắt tích hợp vào EHR: Nâng cao chất lượng ghi chép trong phẫu thuật ung bướu vùng đầu cổ https://news.medxy.ai/ehr-integrated-synoptic-operative-reporting-enhancing-documentation-in-head-and-neck-oncologic-surgery/Medxy AIen2026-09-26T06:33:02-07:00EHR-Integrated Synoptic Operative Reporting: Enhancing Documentation in Head and Neck Oncologic Surgery https://news.medxy.ai/zh/barrett-esophagus-monitoring/Medxy AIzh2026-09-26T06:22:28-07:00荷兰全国研究揭示：Barrett 食管相关异型增生与癌症诊断前内镜监测不足 https://news.medxy.ai/ja/barrett-esophagus-surveillance/Medxy AIja2026-09-26T06:22:02-07:00全国オランダ研究が示した、Barrett食道関連異形成・癌診断前の内視鏡サーベイランスの乏しさ https://news.medxy.ai/vi/barretts-esophagus-study/Medxy AIvi2026-09-26T06:20:12-07:00Nghiên cứu toàn quốc tại Hà Lan cho thấy nội soi giám sát trước chẩn đoán ở Barrett’s esophagus còn rất hạn chế https://news.medxy.ai/dutch-barrett-study/Medxy AIen2026-09-26T06:19:52-07:00Nationwide Dutch Study Reveals Limited Prior Endoscopic Surveillance in Barrett’s Esophagus-Related Dysplasia and Cancer Diagnosis https://news.medxy.ai/zh/liver-cirrhosis-risk/Medxy AIzh2026-09-26T06:19:08-07:00肝硬化短期住院风险可由独特肠道微生物组特征预测：全球宏基因组研究揭示的新认识 https://news.medxy.ai/ja/liver-cirrhosis-risks/Medxy AIja2026-09-26T06:18:49-07:00肝硬変の短期入院リスクを予測する腸内マイクロバイオームの特徴：国際メタゲノム研究からの知見 https://news.medxy.ai/vi/gut-microbiome-liver-cirrhosis/Medxy AIvi2026-09-26T06:18:31-07:00Dấu ấn hệ vi sinh đường ruột đặc trưng dự báo nguy cơ nhập viện ngắn hạn ở xơ gan: Góc nhìn từ nghiên cứu metagenomics toàn cầu https://news.medxy.ai/distinct-gut-microbiome-signatures-predict-short-term-hospitalisation-risk-in-cirrhosis-insights-from-a-global-metagenomic-study/Medxy AIen2026-09-26T06:18:12-07:00Distinct Gut Microbiome Signatures Predict Short-term Hospitalisation Risk in Cirrhosis: Insights from a Global Metagenomic Study https://news.medxy.ai/zh/fatty-liver-cancer/Medxy AIzh2026-09-26T06:17:30-07:00揭示脂肪性肝炎样肝细胞癌：多组学洞察与新兴诊疗路径 https://news.medxy.ai/ja/fatty-liver-cancer-2/Medxy AIja2026-09-26T06:17:09-07:00脂肪肝炎性肝細胞癌を読み解く：マルチオミクスが示す診断・治療の新展開 https://news.medxy.ai/vi/liver-cancer-omics/Medxy AIvi2026-09-26T06:16:49-07:00Giải mã ung thư biểu mô tế bào gan thể gan nhiễm mỡ viêm: góc nhìn đa ômics và các hướng chẩn đoán – điều trị mới nổi https://news.medxy.ai/decoding-steatohepatitic-hepatocellular-carcinoma-multi-omics-insights-and-emerging-diagnostic-therapeutic-pathways/Medxy AIen2026-09-26T06:16:28-07:00Decoding Steatohepatitic Hepatocellular Carcinoma: Multi-Omics Insights and Emerging Diagnostic-Therapeutic Pathways https://news.medxy.ai/zh/predicting-type-1-diabetes-complications/Medxy AIzh2026-09-26T06:13:11-07:00达标时间恶化可预测1型糖尿病微血管并发症：来自5年真实世界研究的启示 https://news.medxy.ai/ja/tir-deterioration-type-1-diabetes/Medxy AIja2026-09-26T06:12:52-07:00TIR悪化は1型糖尿病の微小血管合併症を予測するか──5年間の実臨床研究から見えたこと https://news.medxy.ai/vi/tir-microvascular-complications/Medxy AIvi2026-09-26T06:12:32-07:00TIR xấu đi có dự báo biến chứng vi mạch ở đái tháo đường týp 1 không? Bằng chứng từ nghiên cứu thực tế 5 năm https://news.medxy.ai/worsening-time-in-range-as-a-predictor-of-microvascular-complications-in-type-1-diabetes-insights-from-a-5-year-real-world-study/Medxy AIen2026-09-26T06:12:11-07:00Worsening Time in Range as a Predictor of Microvascular Complications in Type 1 Diabetes: Insights from a 5-Year Real-World Study https://news.medxy.ai/pubertal-delay-associated-with-paternally-derived-15q11-2-q13-duplication-syndrome-and-mkrn3-overexpression-a-case-series/Medxy AIen2026-09-26T06:11:35-07:00Pubertal Delay Associated with Paternally Derived 15q11.2-q13 Duplication Syndrome and MKRN3 Overexpression: A Case Series https://news.medxy.ai/zh/long-read-dsd/Medxy AIzh2026-09-26T06:11:00-07:00长读长测序如何推动性发育差异（DSD）诊断革新与公平性提升 https://news.medxy.ai/vi/long-read-sequencing/Medxy AIvi2026-09-26T06:10:17-07:00Giải trình tự đọc dài: Hướng đi mới cho chẩn đoán và công bằng trong rối loạn phát triển giới tính (DSD) https://news.medxy.ai/harnessing-long-read-sequencing-to-revolutionize-diagnosis-and-equity-in-differences-of-sex-development-dsd/Medxy AIen2026-09-26T06:09:56-07:00Harnessing Long-Read Sequencing to Revolutionize Diagnosis and Equity in Differences of Sex Development (DSD) https://news.medxy.ai/zh/77845-2/Medxy AIzh2026-09-25T08:32:22-07:00探讨妇科癌症姑息性放射治疗的时机及其对临终关怀的影响 https://news.medxy.ai/ja/palliative-radiation-timing/Medxy AIja2026-09-25T08:32:05-07:00婦人科がんにおける緩和的放射線治療の時期と終末期ケアへの影響を考える https://news.medxy.ai/vi/77843-2/Medxy AIvi2026-09-25T08:31:44-07:00Xem xét thời điểm thực hiện xạ trị giảm nhẹ đối với ung thư phụ khoa và ảnh hưởng đến việc chăm sóc giai đoạn cuối đời https://news.medxy.ai/evaluating-the-impact-of-palliative-radiotherapy-timing-on-end-of-life-care-in-gynecologic-malignancies/Medxy AIen2026-09-25T08:31:24-07:00Evaluating the Impact of Palliative Radiotherapy Timing on End-of-Life Care in Gynecologic Malignancies https://news.medxy.ai/zh/vulvar-lymph-node-biopsy/Medxy AIzh2026-09-25T08:30:42-07:00外阴癌前哨淋巴结活检再升级：实时近红外荧光成像提升检出率与安全性 https://news.medxy.ai/ja/vulvar-cancer-sentinel-biopsy/Medxy AIja2026-09-25T08:30:21-07:00外陰癌のセンチネルリンパ節生検を前進させる：近赤外蛍光リアルタイム画像が検出精度と安全性を高める https://news.medxy.ai/vi/vulvar-cancer-biopsy/Medxy AIvi2026-09-25T08:29:57-07:00Nâng cao sinh thiết hạch lính gác trong ung thư âm hộ: Chẩn ảnh huỳnh quang cận hồng ngoại thời gian thực giúp cải thiện phát hiện và an toàn https://news.medxy.ai/advancing-sentinel-lymph-node-biopsy-in-vulvar-cancer-real-time-near-infrared-fluorescence-imaging-enhances-detection-and-safety/Medxy AIen2026-09-25T08:29:37-07:00Advancing Sentinel Lymph Node Biopsy in Vulvar Cancer: Real-Time Near-Infrared Fluorescence Imaging Enhances Detection and Safety https://news.medxy.ai/zh/social-vulnerability-ovarian-cancer/Medxy AIzh2026-09-25T08:28:56-07:00社会脆弱性与卵巢癌临床试验可及性不平等：美国县级分析 https://news.medxy.ai/ja/ovarian-cancer-trial-disparities/Medxy AIja2026-09-25T08:28:39-07:00社会的脆弱性と結び付く卵巣癌臨床試験アクセス格差：米国郡レベル解析 https://news.medxy.ai/vi/ovarian-cancer-trial-disparities-2/Medxy AIvi2026-09-25T08:28:21-07:00Chênh lệch trong khả năng tiếp cận thử nghiệm lâm sàng ung thư buồng trứng gắn với tính dễ bị tổn thương xã hội: Phân tích ở cấp quận tại Hoa Kỳ https://news.medxy.ai/disparities-in-ovarian-cancer-clinical-trial-access-linked-to-social-vulnerability-a-u-s-county-level-analysis/Medxy AIen2026-09-25T08:28:02-07:00Disparities in Ovarian Cancer Clinical Trial Access Linked to Social Vulnerability: A U.S. County-Level Analysis https://news.medxy.ai/zh/laparoscopic-radiofrequency-ablation-vs-myomectomy/Medxy AIzh2026-09-25T08:27:29-07:00腹腔镜射频消融对比肌瘤切除术：对子宫平滑肌瘤症状与生活质量的影响 https://news.medxy.ai/ja/77829-2/Medxy AIja2026-09-25T08:27:11-07:00腹腔鏡下ラジオ波焼灼術と筋腫核出術の比較：子宮平滑筋腫の症状および生活の質（QOL）への影響 https://news.medxy.ai/vi/uterine-fibroid-treatments/Medxy AIvi2026-09-25T08:26:51-07:00Đốt sóng cao tần nội soi hay bóc nhân xơ tử cung: so sánh hiệu quả trên triệu chứng và chất lượng sống ở u xơ tử cung https://news.medxy.ai/laparoscopic-radiofrequency-ablation-versus-myomectomy-comparative-effects-on-uterine-leiomyoma-symptoms-and-quality-of-life/Medxy AIen2026-09-25T08:26:32-07:00Laparoscopic Radiofrequency Ablation versus Myomectomy: Comparative Effects on Uterine Leiomyoma Symptoms and Quality of Life https://news.medxy.ai/zh/hip-extension-vs-position/Medxy AIzh2026-09-25T08:25:50-07:00胎头拨露时髋关节伸展还是常规体位？对首次阴道分娩会阴裂伤的影响 https://news.medxy.ai/ja/hip-extension-labor/Medxy AIja2026-09-25T08:25:30-07:00娩出直前の股関節伸展は有効か？初回経腟分娩における会陰裂傷への影響 https://news.medxy.ai/vi/77823-2/Medxy AIvi2026-09-25T08:25:09-07:00Việc duỗi khớp háng ngay trước khi sổ thai có hiệu quả không? Ảnh hưởng đến rách tầng sinh môn trong lần sinh thường đầu tiên https://news.medxy.ai/hip-extension-versus-usual-positioning-at-crowning-impact-on-perineal-lacerations-in-first-vaginal-deliveries/Medxy AIen2026-09-25T08:24:51-07:00Hip Extension Versus Usual Positioning at Crowning: Impact on Perineal Lacerations in First Vaginal Deliveries https://news.medxy.ai/zh/new-hope-autoimmune-hepatitis/Medxy AIzh2026-09-25T08:24:13-07:00Zetomipzomib 为难治性自身免疫性肝炎带来新希望：PORTOLA 2a 期研究解读 https://news.medxy.ai/ja/zetomipzomib-potential/Medxy AIja2026-09-25T08:23:52-07:00難治性自己免疫性肝炎に光明か：第2a相PORTOLA試験が示したゼトミプゾミブの可能性 https://news.medxy.ai/vi/zetomipzomib-autoimmune-hepatitis/Medxy AIvi2026-09-25T08:23:29-07:00Zetomipzomib cho thấy triển vọng ở viêm gan tự miễn khó điều trị: Những ghi nhận từ nghiên cứu pha 2a PORTOLA https://news.medxy.ai/zetomipzomib-shows-promise-in-difficult-to-treat-autoimmune-hepatitis-insights-from-the-phase-2a-portola-study/Medxy AIen2026-09-25T08:23:09-07:00Zetomipzomib Shows Promise in Difficult-to-Treat Autoimmune Hepatitis: Insights from the Phase 2a PORTOLA Study https://news.medxy.ai/ja/77783-2/Medxy AIja2026-09-25T08:09:16-07:00入院中のCGM、インスリンポンプ、AIDシステムの安全な使用法：国際的なポジションステートメントの要点解説 https://news.medxy.ai/vi/cgm-insulin-aid-guidelines/Medxy AIvi2026-09-25T08:08:43-07:00Ứng dụng thực hành CGM, bơm insulin và AID trong nội trú: Khuyến nghị then chốt từ một tuyên bố quan điểm quốc tế https://news.medxy.ai/zh/cgm-insulin-pump-aid-safety/Medxy AIzh2026-09-25T08:08:08-07:00住院期如何安全使用CGM、胰岛素泵与AID系统：国际立场声明要点解读 https://news.medxy.ai/practical-inpatient-use-of-cgm-insulin-pumps-and-aid-systems-key-recommendations-from-an-international-position-statement/Medxy AIen2026-09-25T08:07:38-07:00Practical Inpatient Use of CGM, Insulin Pumps, and AID Systems: Key Recommendations from an International Position Statement https://news.medxy.ai/zh/ultrasound-guided-afib-ablation/Medxy AIzh2026-09-25T08:06:39-07:00ULYSSES 试验：超声引导可显著降低心房颤动消融中的血管并发症 https://news.medxy.ai/ja/ulyssses-trial/Medxy AIja2026-09-25T08:06:21-07:00ULYSSES試験：超音波ガイドで心房細動アブレーションの血管合併症が大幅減少 https://news.medxy.ai/vi/ulyssses-ultrasound-guide/Medxy AIvi2026-09-25T08:06:02-07:00Thử nghiệm ULYSSES: Hướng dẫn siêu âm giúp giảm rõ rệt biến chứng mạch máu trong triệt đốt rung nhĩ https://news.medxy.ai/the-ulysses-trial-ultrasound-guidance-significantly-reduces-vascular-complications-in-atrial-fibrillation-ablation/Medxy AIen2026-09-25T08:05:44-07:00The ULYSSES Trial: Ultrasound Guidance Significantly Reduces Vascular Complications in Atrial Fibrillation Ablation https://news.medxy.ai/ja/afib-cardiac-resynchronization/Medxy AIja2026-09-25T08:05:00-07:00心房細動における心臓再同期療法：房室結節アブレーション併用の有無を比較したCAAN-AF試験 https://news.medxy.ai/vi/cardiac-resynchronization-af/Medxy AIvi2026-09-25T08:04:40-07:00Liệu pháp tái đồng bộ tim trong rung nhĩ: có cần triệt đốt nút nhĩ thất hay không? Kết quả thử nghiệm CAAN-AF https://news.medxy.ai/cardiac-resynchronization-therapy-with-or-without-atrioventricular-node-ablation-in-atrial-fibrillation-the-caan-af-trial/Medxy AIen2026-09-25T08:04:23-07:00Cardiac Resynchronization Therapy With or Without Atrioventricular Node Ablation in Atrial Fibrillation: The CAAN-AF Trial https://news.medxy.ai/zh/mtmr4-gene-variants/Medxy AIzh2026-09-25T08:03:46-07:00MTMR4基因变异：在1型与2型长QT综合征中的致心律失常风险呈相反影响 https://news.medxy.ai/ja/mtmr4-gene-variants-2/Medxy AIja2026-09-25T08:03:25-07:00MTMR4基因变异：对1型与2型长QT综合征心律失常风险的相反影响 https://news.medxy.ai/vi/mtmr4-gen-variant-risk/Medxy AIvi2026-09-25T08:03:06-07:00Biến thể gen MTMR4: Tác động trái ngược lên nguy cơ loạn nhịp trong hội chứng QT dài тип 1 và тип 2 https://news.medxy.ai/mtmr4-gene-variants-divergent-impact-on-arrhythmic-risk-in-type-1-and-2-long-qt-syndrome/Medxy AIen2026-09-25T08:02:46-07:00MTMR4 Gene Variants: Divergent Impact on Arrhythmic Risk in Type 1 and 2 Long QT Syndrome https://news.medxy.ai/zh/atrial-mechanical-dysfunction/Medxy AIzh2026-09-25T08:02:04-07:00窦性心律下转甲状腺素蛋白淀粉样变性心肌病患者的心房机械功能障碍：卒中风险的新预测因子 https://news.medxy.ai/ja/atrial-function-stroke-risk/Medxy AIja2026-09-25T08:01:45-07:00洞調律のトランスサイレチンアミロイド心筋症における心房機械機能障害は脳卒中リスクの有力予測因子 https://news.medxy.ai/vi/atrial-mechanical-dysfunction-stroke-risk/Medxy AIvi2026-09-25T08:01:20-07:00Rối loạn chức năng cơ học nhĩ: dấu ấn dự báo nguy cơ đột quỵ ở bệnh nhân bệnh cơ tim nhiễm amyloid transthyretin còn nhịp xoang https://news.medxy.ai/atrial-mechanical-dysfunction-as-a-predictor-of-stroke-risk-in-transthyretin-amyloid-cardiomyopathy-patients-in-sinus-rhythm/Medxy AIen2026-09-25T08:00:59-07:00Atrial Mechanical Dysfunction as a Predictor of Stroke Risk in Transthyretin Amyloid Cardiomyopathy Patients in Sinus Rhythm https://news.medxy.ai/zh/77759-2/Medxy AIzh2026-09-25T08:00:18-07:00心脏淀粉样变性中潜藏的心律失常负荷 https://news.medxy.ai/ja/amyloidosis-arrhythmia-excalibur/Medxy AIja2026-09-25T07:59:58-07:00心アミロイドーシスに潜む不整脈負荷：EXCALIBUR植込み型ループレコーダー研究から見えた知見 https://news.medxy.ai/vi/arrhythmia-amyloidosis-heart/Medxy AIvi2026-09-25T07:59:36-07:00Gánh nặng rối loạn nhịp trong amyloidosis tim: Những phát hiện từ nghiên cứu EXCALIBUR với thiết bị ghi nhận nhịp tim cấy ghép https://news.medxy.ai/unveiling-arrhythmic-burden-in-cardiac-amyloidosis-insights-from-the-excalibur-implantable-loop-recorder-study/Medxy AIen2026-09-25T07:59:16-07:00Unveiling Arrhythmic Burden in Cardiac Amyloidosis: Insights from the EXCALIBUR Implantable Loop Recorder Study https://news.medxy.ai/zh/ldl-cholesterol-thrombosis-risk/Medxy AIzh2026-09-25T07:58:29-07:00遗传决定的 LDL 胆固醇差异与静脉血栓栓塞风险：影响有限 https://news.medxy.ai/ja/ldl-genetic-risk/Medxy AIja2026-09-25T07:58:10-07:00LDLコレステロールの遺伝的差異と静脈血栓塞栓症リスクへの限定的な影響 https://news.medxy.ai/vi/ldl-cholesterol-variation/Medxy AIvi2026-09-25T07:57:48-07:00Biến thiên LDL cholesterol do di truyền và tác động hạn chế lên nguy cơ huyết khối tĩnh mạch thuyên tắc https://news.medxy.ai/genetically-mediated-ldl-cholesterol-variations-and-their-limited-impact-on-venous-thromboembolism-risk/Medxy AIen2026-09-25T07:57:27-07:00Genetically Mediated LDL Cholesterol Variations and Their Limited Impact on Venous Thromboembolism Risk https://news.medxy.ai/zh/77749-2/Medxy AIzh2026-09-25T07:56:44-07:00FFR-CT改善稳定性冠状动脉疾病预后的潜力 https://news.medxy.ai/ja/ffr-ct-coronary-disease/Medxy AIja2026-09-25T07:56:24-07:00安定冠動脈疾患の予後を高めるFFR-CTの可能性：全国コホート研究が示す新知見 https://news.medxy.ai/vi/77747-2/Medxy AIvi2026-09-25T07:56:02-07:00Tiềm năng của FFR-CT trong việc cải thiện tiên lượng bệnh động mạch vành ổn định https://news.medxy.ai/enhancing-prognosis-in-stable-coronary-artery-disease-insights-from-a-nationwide-cohort-on-ffr-ct/Medxy AIen2026-09-25T07:55:40-07:00Enhancing Prognosis in Stable Coronary Artery Disease: Insights from a Nationwide Cohort on FFR-CT https://news.medxy.ai/zh/77744-2/Medxy AIzh2026-09-25T07:54:54-07:00血管外植入式除颤器的临床实际应用结果：来自Enlighten上市后注册研究的发现 https://news.medxy.ai/ja/icd-clinical-results/Medxy AIja2026-09-25T07:54:33-07:00血管外植込み型除細動器の実臨床成績：Enlighten市販後レジストリからの知見 https://news.medxy.ai/vi/ev-icd-clinical-results/Medxy AIvi2026-09-25T07:54:09-07:00EV-ICD trong thực hành lâm sàng: Kết quả 1 năm từ Enlighten Post Approval Registry https://news.medxy.ai/real-world-outcomes-of-the-extravascular-implantable-cardioverter-defibrillator-insights-from-the-enlighten-post-approval-registry/Medxy AIen2026-09-25T07:53:47-07:00Real-World Outcomes of the Extravascular Implantable Cardioverter Defibrillator: Insights from the Enlighten Post Approval Registry https://news.medxy.ai/zh/sotatercept-pulmonary-hypertension-2/Medxy AIzh2026-09-25T07:53:00-07:00Sotatercept通过优化肺动脉高压的心脏力学改善右心功能 https://news.medxy.ai/ja/77738-2/Medxy AIja2026-09-25T07:52:40-07:00ソタテルセプトは、肺動脈性肺高血圧症における心臓の力学特性を最適化することで、右心機能を改善する https://news.medxy.ai/vi/sotatercept-heart-function/Medxy AIvi2026-09-25T07:52:17-07:00Sotatercept giúp tối ưu cơ học để cải thiện chức năng tim phải trong tăng áp động mạch phổi https://news.medxy.ai/sotatercept-enhances-right-heart-function-by-optimizing-mechanics-in-pulmonary-arterial-hypertension/Medxy AIen2026-09-25T07:51:58-07:00Sotatercept Enhances Right Heart Function by Optimizing Mechanics in Pulmonary Arterial Hypertension